In the control group, in which mice were injected with the control CE146T cells, all mice (100%) developed several distal metastatic tumors within 64 days after cancer cell injection, whereas only one mouse (20%) had one small distal metastatic tumor in the ADAM9 knockdown group (Figure 2C). Here, ADAM9 is linked to cancer.